HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Lauder Exits Mass Market Jungle With Decision To Sell Jane

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Estee Lauder's decision to sell its mass market teen cosmetics brand jane reflects the company's desire to focus on the mid-tier and prestige beauty markets, CEO Fred Langhammer stated, announcing the decision Jan. 29 during a sales and earnings call

You may also be interested in...



Lauder Is “Crazy In Love” With Hilfiger-Knowles Partnership

Estee Lauder is looking to revitalize its Tommy Hilfiger fragrance brand this fall through an endorsement deal with singer Beyonce Knowles, the company announced Jan. 27

Lauder Banks On Kohl’s Beauty In Distribution Expansion Move

Estee Lauder is launching an initiative to develop multiple beauty brands for distribution exclusively in Kohl's as part of an alliance with the retailer announced Oct. 28

Jane Repositioning Aims To Broaden Customer Base

Estee Lauder is repositioning jane cosmetics in an effort to return the line to its beauty-oriented, value heritage, General Manager Todd First said

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

See All
UsernamePublicRestriction

Register

RS011865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By